The cash-strapped federal government’s ability to fund stem cell research has become severely limited, the top official in charge of the research told attendees at the World Stem Cell Summit on Wednesday. So the private sector is being encouraged to play a larger role, to take over some functions, provide order and reduce needless duplication of effort.
Recent Posts
- CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission
- Stem cell therapy linked to lower risk of heart failure after a heart attack
- Embryo-Like ‘Blood Factories’ Could One Day Supplement Donations
- Long-Term Growth Hormone Therapy Boosts Pediatric Stem Cells
- New UCLA drug could restore heart and organ function
- Parkinson’s treatment tested at UW showing promise in first clinical trial
